Related Experiment Videos
Expression of neural BC200 RNA in human tumours
1Department of Biochemistry, Mount Sinai School of Medicine, New York, NY 10029, USA.
Abstract:
BC200 RNA is a 200-nucleotide-long non-messenger RNA that is selectively expressed in the primate nervous system, where it has been identified in somatodendritic domains of a subset of neurons. BC200 RNA is not normally expressed in non-neuronal somatic cells; it has been shown, however, to be expressed in germ cells and in cultured immortal cell lines of various non-neural origins. In order to investigate whether the neuron-specific expression of BC200 RNA is also deregulated during tumourigenesis in non-neural human tissues, 80 different tumour specimens, representing 19 different tumour types, were screened for the presence of the RNA. BC200 RNA was expressed in carcinomas of the breast, cervix, oesophagus, lung, ovary, parotid, and tongue, but not in corresponding normal tissues. BC200 RNA was not detectable in bladder, colon, kidney, or liver carcinoma tissues examined in this study. These results demonstrate that BC200 expression is deregulated under certain neoplastic conditions. The expression of BC200 RNA in non-neural tumours may indicate a functional interrelationship with induction and/or progression of such tumours.
Insights
BC200 RNA, a non-coding RNA normally found in the brain, is abnormally expressed in several non-neural tumors. This deregulation suggests a potential role for BC200 RNA in cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Neuroscience
Background:
- BC200 RNA is a 200-nucleotide non-messenger RNA selectively expressed in the primate nervous system.
- It is typically found in specific neuronal populations but not in normal somatic cells.
- BC200 RNA expression has been observed in germ cells and immortalized non-neural cell lines.
Purpose of the Study:
- To investigate the deregulation of BC200 RNA expression in non-neural human tumors.
- To determine if BC200 RNA expression is altered during tumorigenesis in non-neural tissues.
Main Methods:
- Screening of 80 tumor specimens from 19 different tumor types for BC200 RNA presence.
- Comparison of BC200 RNA expression in tumor tissues versus corresponding normal tissues.
Main Results:
- BC200 RNA was detected in carcinomas of the breast, cervix, esophagus, lung, ovary, parotid, and tongue.
- BC200 RNA was not found in normal tissues from these sites.
- BC200 RNA was not detectable in examined bladder, colon, kidney, or liver carcinomas.
Conclusions:
- BC200 RNA expression is deregulated in specific non-neural human tumors.
- Aberrant BC200 RNA expression in tumors suggests a potential functional role in tumorigenesis.
- This finding highlights a possible link between BC200 RNA and cancer induction or progression.